309 related articles for article (PubMed ID: 22965061)
21. Systems biology approaches to develop innovative strategies for lung cancer therapy.
Viktorsson K; Lewensohn R; Zhivotovsky B
Cell Death Dis; 2014 May; 5(5):e1260. PubMed ID: 24874732
[TBL] [Abstract][Full Text] [Related]
22. Applications of personalised signalling network models in precision oncology.
Hastings JF; O'Donnell YEI; Fey D; Croucher DR
Pharmacol Ther; 2020 Aug; 212():107555. PubMed ID: 32320730
[TBL] [Abstract][Full Text] [Related]
23. Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub.
Csermely P; Korcsmáros T; Nussinov R
Semin Cell Dev Biol; 2016 Oct; 58():55-9. PubMed ID: 27395026
[TBL] [Abstract][Full Text] [Related]
24. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
Verkhivker GM
Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
[TBL] [Abstract][Full Text] [Related]
25. Building patient-specific models for receptor tyrosine kinase signaling networks.
Ebata K; Yamashiro S; Iida K; Okada M
FEBS J; 2022 Jan; 289(1):90-101. PubMed ID: 33755310
[TBL] [Abstract][Full Text] [Related]
26. Network-based cancer precision medicine: A new emerging paradigm.
Tan A; Huang H; Zhang P; Li S
Cancer Lett; 2019 Aug; 458():39-45. PubMed ID: 31125640
[TBL] [Abstract][Full Text] [Related]
27. Diversified Control Paths: A Significant Way Disease Genes Perturb the Human Regulatory Network.
Wang B; Gao L; Zhang Q; Li A; Deng Y; Guo X
PLoS One; 2015; 10(8):e0135491. PubMed ID: 26284649
[TBL] [Abstract][Full Text] [Related]
28. Network-Oriented Approaches to Anticancer Drug Response.
Lecca P; Re A
Methods Mol Biol; 2017; 1513():101-117. PubMed ID: 27807833
[TBL] [Abstract][Full Text] [Related]
29. Long range personalized cancer treatment strategies incorporating evolutionary dynamics.
Yeang CH; Beckman RA
Biol Direct; 2016 Oct; 11(1):56. PubMed ID: 27770811
[TBL] [Abstract][Full Text] [Related]
30. Influence Networks Compared with Reaction Networks: Semantics, Expressivity and Attractors.
Fages F; Martinez T; Rosenblueth DA; Soliman S
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(4):1138-1151. PubMed ID: 29994637
[TBL] [Abstract][Full Text] [Related]
31. Cell-to-cell variability in cell death: can systems biology help us make sense of it all?
Xia X; Owen MS; Lee RE; Gaudet S
Cell Death Dis; 2014 May; 5(5):e1261. PubMed ID: 24874733
[TBL] [Abstract][Full Text] [Related]
32. An efficient algorithm for identifying primary phenotype attractors of a large-scale Boolean network.
Choo SM; Cho KH
BMC Syst Biol; 2016 Oct; 10(1):95. PubMed ID: 27717349
[TBL] [Abstract][Full Text] [Related]
33. Oxidative Molecular Mechanisms Underlying Liver Diseases: From Systems Biology to the Personalized Medicine.
Vergara D; Casadei-Gardini A; Giudetti AM
Oxid Med Cell Longev; 2019; 2019():7864316. PubMed ID: 31281591
[No Abstract] [Full Text] [Related]
34. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
35. Network-based drugs and biomarkers.
Erler JT; Linding R
J Pathol; 2010 Jan; 220(2):290-6. PubMed ID: 19921715
[TBL] [Abstract][Full Text] [Related]
36. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
[TBL] [Abstract][Full Text] [Related]
37. Use of systems biology to decipher host-pathogen interaction networks and predict biomarkers.
Dix A; Vlaic S; Guthke R; Linde J
Clin Microbiol Infect; 2016 Jul; 22(7):600-6. PubMed ID: 27113568
[TBL] [Abstract][Full Text] [Related]
38. Revolutionizing medicine in the 21st century through systems approaches.
Hood L; Balling R; Auffray C
Biotechnol J; 2012 Aug; 7(8):992-1001. PubMed ID: 22815171
[TBL] [Abstract][Full Text] [Related]
39. A systems biology road map for the discovery of drugs targeting cancer cell metabolism.
Alberghina L; Gaglio D; Moresco RM; Gilardi MC; Messa C; Vanoni M
Curr Pharm Des; 2014; 20(15):2648-66. PubMed ID: 23859611
[TBL] [Abstract][Full Text] [Related]
40. Label propagation defines signaling networks associated with recurrently mutated cancer genes.
Cakir M; Mukherjee S; Wood KC
Sci Rep; 2019 Jun; 9(1):9401. PubMed ID: 31253832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
